Pharmacists in Milwaukie, Oregon
81 Pharmacists found in Milwaukie
Mr. Scott A Mitchell, RPH CGP
Pharmacist - Geriatric
4560 Se International Way, Consonus Pharmacy Services, Milwaukie, OR 97222
971-206-5200 503-652-0383
Dr. Steven Cheung, PHARM. D, RPH
Pharmacist
4560 Se International Way Ste 101, Milwaukie, OR 97222
971-206-5205 503-652-0383
Sze Ming Li, PHARM.D.
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3300 Se Dwyer Dr, Ste 304, Milwaukie, OR 97222
503-513-8343
Dr. Teodora Petrova Raducheva, PHARMD
Pharmacist
4560 Se International Way Ste 101, Milwaukie, OR 97222
971-206-5205
Dr. Teresa Marie Maddalone Swift, PHARMD, BCPS
Pharmacist - Pharmacotherapy
10202 Se 32nd Ave, Milwaukie, OR 97222
503-513-2121 503-513-2105
Ms. Terri Lee Fagan, RPH, CGP
Pharmacist
4560 Se International Way, Suite 101, Milwaukie, OR 97222
971-206-5205
Mr. Thomas Earl West, M.S., R.PH.
Pharmacist
16246 Se Mcloughlin Blvd, Milwaukie, OR 97267
503-657-9422 503-656-0278
Victor J Abreu
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
10330 Se 32nd Ave Ste 325, Milwaukie, OR 97222
503-416-1960 503-416-1959
Ms. Wendy J Eckhart, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3300 Se Dwyer Dr, Suite 304, Milwaukie, OR 97222
503-513-8343 503-513-8351
Wilfrid S Lin, RPH
Pharmacist
16246 Se Mcloughlin Blvd, Milwaukie, OR 97267
503-657-9422 503-656-7785
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.